Stephen Abreu has been appointed by the Board as Executive Director. He will lead the organization's overall strategy and ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

ATLANTA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- SC24 -- NVIDIA today announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source ...

Assessing patient fitness involves more than evaluating chronological age, noted Brandon Blue, MD, of the Moffitt Cancer ...

Minimal residual disease (MRD) has emerged as a significant marker in the treatment of multiple myeloma (MM), allowing clinicians to make more informed decisions about therapy. MRD testing helps gauge ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

Mississippi Baptist Medical Center teamed up with Genentech to bring awareness of healthy lungs for Lung Cancer Awareness ...

Flagship Pioneering-founded Valo Health has announced the appointment of Dr Brian Alexander as its new CEO. Additionally, ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.